Answers are grounded in this paper and cite their sources.
When susceptible cells are exposed to diphtheria toxin (Mr, 62,000) the N-terminal 21,150-dalton A fragment of toxin reaches the cytoplasm, where it catalyzes the transfer of adenosinediphosphoribose from nicotinamide adenine dinucleotide to elongation factor 2 (EF2). Adenosinediphosphoribose-EF2 is inactive, so that protein synthesis is blocked. Using a simple, rapid assay for the amount of adenosinediphosphoribosylatable EF2 in unfractionated lysates of cultured cells we have followed the kinetics of inactivation of EF2 in CV-1 and BHK cells exposed to diphtheria toxin. With both cell lines a lag was observed between the addition of toxin to the cells and the adenosinediphosphoribosylation of EF2. The lag decreased with increasing toxin concentration until a limiting value of about 12 min was reached. The rate of adenosinediphosphoribosylation of EF2 after the lag was 10 to 20 times more rapid in CV-1 cells than in BHK cells exposed to the same toxin concentration. The concentration of fragment A active in the cytoplasm of toxin-treated cells was estimated from the rate of adenosinediphosphoribosylation observed. Comparison of these estimates with data from studies of binding of 125I-toxin to cells suggests that the fragment A of only a minor fraction of toxin molecules bound to cell surface receptors reaches the cytoplasm and participates in the inactivation of EF2. A model summarizing our current views on the process by which fragment A enters cells is presented.
No takes yet. Share an insight, caveat, or question.
Moynihan et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: